Literature DB >> 6973343

Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients.

L Grossman, P Barland.   

Abstract

Anti-histone antibodies were measured in a group of patients with drug-induced lupus erythematosus and in asymptomatic patients with drug-induced antinuclear antibodies (DANA). Anti-histone antibodies were found in the majority of drug-induced lupus patients. DANA patients had lower titers of ANA and no detectable anti-histone activity. Longitudinal studies of the drug-induced lupus patients showed a gradual fall in the ANA and anti-histone titers. Our data suggest that the immune response in the drug-induced lupus patients is similar to but more intense than that seen in the DANA patients. Possible factors altering the immune response in these 2 groups are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973343     DOI: 10.1002/art.1780240710

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

Review 1.  Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus.

Authors:  G Q Shen; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.

Authors:  R N Hobbs; A L Clayton; R M Bernstein
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

3.  Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.

Authors:  R L Rubin; S A Bell; R W Burlingame
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  High prevalence of antibodies to histones among patients with primary biliary cirrhosis.

Authors:  E Penner; S Muller; D Zimmermann; M H Van Regenmortel
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  Procainamide elicits a selective autoantibody immune response.

Authors:  R L Rubin; G Reimer; E M McNally; S R Nusinow; R P Searles; E M Tan
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.